Advocacy
74 articles
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
Steven Merlin and Davi D’Agostino Team Up to Help Others
Pancreatic cancer patient advocates Steven Merlin and Davi D’Agostino have joined to pool expertise and information for other patients.
In Safe Hands: Selecting the Right Whipple Surgeon
The Whipple procedure is a complex surgery–how do you find an expert with the vast experience needed for your surgery?
PRECEDE Trial Sets Survival Rate Goal
Dr. Raymond Wadlow explains how earlier detection of high-risk people is key the PRECEDE trial’s goal to increase pancreatic cancer survival rates.
LET’S WIN! PANCREATIC CANCER Turns 5!
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.
ASCO GI Symposium Features a Broad Range of Pancreatic Cancer Research
Researchers at ASCO GI 2024 reported on research in health disparities, KRAS and other genetic mutations, and novel treatments.
PancChat Featured in a Journal Article
PancChat co-host Dr. Niraj Gusani has coauthored an article about the advantages of social media for oncology surgeons.
Let’s Win Rings the Nasdaq Closing Bell for Pancreatic Cancer Awareness Month
Let’s Win marked Pancreatic Cancer Awareness Month by ringing the closing bell at the Nasdaq Stock Market on Monday November 12, 2018.
Let’s Win Rings the Nasdaq Closing Bell for Pancreatic Cancer Awareness
The Let’s Win team and supporters rang the closing bell at Nasdaq on November 22, 2019, to mark World Pancreatic Cancer Day on November 21.
The Whys and Hows of Pancreatic Enzyme Replacement Therapy
Pancreatic enzyme replacement therapy (PERT), is an important part of treatment that is often not properly utilized, but a new tool can help.